MACCABI SHEIRUTEI BRIUT FOUNDATION

Their core work

Maccabi Healthcare Services is one of Israel's largest health maintenance organizations (HMOs), providing primary and specialist care to over two million members. In H2020, they contribute real-world clinical data, patient cohorts, and healthcare delivery infrastructure to European research consortia focused on chronic disease management and digital health. Their participation brings the perspective of a large-scale operating healthcare provider — not a research lab — enabling projects to validate tools and interventions in actual clinical settings.

What they specialise in

How they've shifted over time

Their early H2020 involvement (2015) began with DECI, a project on digital inclusion — suggesting an initial interest in accessible digital services for vulnerable populations. From 2020 onward, their focus shifted decisively toward chronic disease management and precision medicine, with ADLIFE targeting personalized care platforms and SOPHIA tackling obesity treatment stratification using federated data. The trajectory shows a clear move from general digital health toward data-driven, condition-specific clinical decision support.

Maccabi is moving toward precision medicine and algorithm-driven treatment decisions, making them a strong partner for projects needing large real-world patient datasets and clinical validation environments.

How they like to work

Maccabi operates exclusively as a participant or third party — never as a coordinator — which is consistent with their role as a healthcare provider contributing clinical infrastructure and patient data rather than driving research agendas. With 64 unique partners across 16 countries, they connect into large European consortia where their value is real-world deployment and validation. They are a reliable clinical endpoint partner, not a research lead.

Maccabi has collaborated with 64 unique partners across 16 countries, indicating broad European network reach despite being based in Israel. Their connections span multiple healthcare systems, which is valuable for multi-country clinical validation studies.

What sets them apart

Maccabi's key differentiator is scale: as an HMO serving millions of patients, they offer access to massive longitudinal health records and diverse patient populations for research validation. Unlike university hospitals that contribute research expertise, Maccabi brings the perspective and data of a primary care provider operating at population level. For any consortium needing real-world clinical deployment sites or large federated patient datasets, they are a rare non-academic healthcare partner with proven EU project experience.

Highlights from their portfolio

• SOPHIA
  Ambitious obesity phenotyping project running until 2026, using federated databases and algorithmic treatment stratification — represents Maccabi's deepest engagement with precision medicine.
• ADLIFE
  Large-scale deployment of personalized care platforms for advanced chronic diseases, directly testing digital health tools in real clinical environments.